On a relative basis, the stock has outperformed the S&P 500 by 4.49% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 1.22% in the last 1 week, and is up 6.17% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The company shares have rallied 12.37% from its 1 Year high price. On Jul 8, 2016, the shares registered one year high at $82.42 and the one year low was seen on Feb 9, 2016. The 50-Day Moving Average price is $78.39 and the 200 Day Moving Average price is recorded at $72.06.
The stock has recorded a 20-day Moving Average of 4.74% and the 50-Day Moving Average is 6.66%.
Quest Diagnostics Incorporated (NYSE:DGX): stock turned positive on Friday. Though the stock opened at $81.78, the bulls momentum made the stock top out at $82.42 level for the day. The stock recorded a low of $81.4 and closed the trading day at $82.23, in the green by 1.23%. The total traded volume for the day was 1,516,646. The stock had closed at $81.23 in the previous days trading.
In an insider trading activity, Doherty Catherine T., officer (SVP, Clin. Franchise Solutions) of Quest Diagnostics Inc, unloaded 47,334 shares at an average price of $77.27 on May 27, 2016. The total amount of the transaction was worth $3,657,498, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Quest Diagnostics Incorporated is a provider of diagnostic testing information services. The Company consists of two businesses: Diagnostic Information Services and Diagnostic Solutions. Diagnostic Information Services business, consists of two parts, develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, patients and other customers. Diagnostics Information Services business also provides diagnostic information services, which includes providing clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services and drugs-of-abuse testing. Diagnostic Solutions includes the Companys other businesses, including central laboratory testing for pharmaceutical and medical device clinical trials, risk assessment services, diagnostic products and healthcare information technology.